pidemiological studies have determined that age, per se, is the major risk for coronary artery disease, hypertension, and resultant chronic heart failure, which are the major diseases that affect our society. One interpretation of the marked effect of advancing age on the occurrence of these diseases is that aging is synonymous with these disease processes; another is that other defined risk factors for these diseases, eg, hypertension or diabetes, vary in number or severity with increasing age. Still another viewpoint posits that increasing age is the equivalent of an increased time at risk. A contrasting view is that cardiovascular structure and function change with time because of an aging process that alters the substrate on which pathophysiologic mechanisms interact. 1 According to this view, ageassociated changes become partners with these disease mechanisms to determine the threshold for clinical signs and symptoms, severity, and prognosis of cardiovascular diseases in older persons. In this regard, the enhanced risk for older persons is attributable to an interaction between age and time-of-disease presence. Researchers of heart disease mechanisms must "fess up" to the recognition of the reality of these age-disease interactions. In reality, interactions are more complex and involve age, disease, lifestyle (including environment), and the genetic components of each of these. We have begun to understand some aspects of the former three, but the latter likely involves complex genetic traits that by and large presently remain elusive.
Quantitative information on cardiovascular structure and function in health to define specific phenotypic characteristics or biomarkers of cardiovascular aging is necessary for an in-depth analysis of genetic contributions to aging and disease. During the last three decades, a sustained effort has been applied to characterize the effects of aging on multiple aspects of cardiovascular structure and function in study populations, such as the Baltimore Longitudinal Study on Aging (BLSA). In this study, community-dwelling volunteers are rigorously screened to detect both clinical and occult cardiovascular disease and are characterized with respect to lifestyle (eg, diet and exercise habits) in an attempt to clarify the interactions of these factors and those changes that result from aging per se. 2 Perspectives gleaned from these and other studies in humans and from studies in animal models indicate that one of the most prominent characteristics of cardiovascular aging in the absence of detectable disease is a reduction in the cardiac reserve, attributable in large measure to a reduction in the maximum heart rate that can be achieved during stress (Figure) . This impaired cardioacceleration during stress is shared by humans and rodents. In humans, the age-associated heart deficit during treadmill running can be roughly estimated by the algorithm: 220 minus age in years.
Whereas impaired cardioacceleration during stress is a candidate biomarker of aging in mammals, its genetic basis and that of other notable age-associated changes in cardiovascular structure and function 3 have essentially not been addressed. This is attributable, in part, to the complex interactions of age, disease, lifestyle, and genetics, noted above. One escape route from the dilemma of these interactions is a search for genetic markers for heart rate reserve impairment in less complex organisms than humans and rodents. However, a delineation of the cardiovascular aging phenotype in less complex organisms is paramount to unraveling potential genetic mechanisms involved. In this issue of Circulation Research, Paternostro et al 4 have developed methods to study cardiac function in vivo in Drosophila melanogaster, the fruit fly, of different adult ages. Using two different approaches to stress the heart (elevated ambient temperature and external electrical pacing), these authors found that the maximal heart rate that can be achieved in these flies is substantially reduced with adult aging. The maximal heart rate decline with aging in flies over the adult range is linear, analogous to the age-associated decline in humans ( Figure) . Other aspects of cardiac aging in Drosophila, including an age-associated increase in heart rhythm disturbances, are also described.
The choice by Paternostro et al 4 to target Drosophila melanogaster for characterization of the phenotype of heart aging was undoubtedly dictated by the fact that it is the first organism possessing a circulatory system to have its genome completely sequenced. 5 Additionally, the Drosophila genome is relevant to cardiac disease and development in mammals. A recent, large-scale survey of 287 human disease genes within the Drosophila genome showed that 62% have conserved homologues. 6 In other studies, Drosophila mutations in the potassium channel gene HERG (human ether-a-go-go-related gene), which causes long-QT syndrome in humans, 7 were identified by the homology of HERG to the Drosophila potassium channel gene ether-a-go-golP. 8 An important gene that regulates cardiac development in Drosophila that has also been shown to be relevant to cardiac development in higher organisms is the cardiac transcription factor (Nkx2-5/Csx) 9,10 in mouse, a homologue of the Drosophila gene tinman. 11 There is also evidence that myocyte enhancer binding factor-2 transcription factors and transforming growth factor-␤ signaling are involved in cardiogenesis in both flies and mammals. 11 These discoveries about cardiac development in Drosophila complement those made in the zebrafish vertebrate model. 12 The fruit fly, because of its small number of genes (13 600) and short lifespan, 13 has already been commonly used as a model organism for studying the genetics of aging that pertain to longevity. However, studies of this sort in Drosophila, like others of promising models used in research on aging in yeast, worms, and bacteria, 14 -17 have focused mainly on the replicative senescence of actively dividing cells. Paternostro et al 4 logically propose that genetic screens in flies, on the basis of deviations from the differences in heart rates under stress, could be exploited to identify conserved genes across species that are linked to the rate at which the heart beats and that these genes may be the same as those that are linked to age-associated decline in heart rate and to other aspects of other altered cardiac function declines that accompany aging in Drosophila.
To date there have been no studies describing pacemaker-like cells in Drosophila. But there is a great deal of information on mechanisms that regulate the heart rate in mammals that may provide some clues that are relevant to the search for changes in specific gene expression that may underlie the observed ageassociated impairment in cardioacceleration during stress. Impaired cardioacceleration during stress could involve regulatory factors that control the intrinsic pacemaker function of specialized sinoatrial pacemaker cells or modulation of these factors by stretch or autonomic receptor stimulation.
The intrinsic heart rate in humans, ie, that measured in the presence of sympathetic and vagal blockade, decreases between early adulthood and middle age. 18 Classic electrophysiological studies have identified several ionic currents involved in regulating the intrinsic heart rate 19 that are prime candidates as mechanisms for alterations in heart rate control with aging. Recent studies in isolated mammalian sinoatrial nodal cells have discovered a prominent role of intracellular Ca 2ϩ in the heart rate modulation. 20 -25 More specifically, localized Ca 2ϩ release via ryanodine receptors beneath the sinoatrial nodal cell-surface membrane occurring during the interbeat interval activates the Na ϩ -Ca 2ϩ exchanger, producing an inward current; this augments the slope of the membrane depolarization before the subsequent action potential, leading to its earlier occurrence and, thus, to an increase in heart rate. 26 Accordingly, in embryonic stem cells that develop along the cardiac lineage in vitro, the presence of a ryanodine receptor (RyR2) is required for the progressive increase in heart rate with time 27 ; in the absence of an Na ϩ -Ca 2ϩ exchange, mice die in utero, 28, 29 their hearts beatless, although the response to external pacing remains intact. 28 (So! Now we have wingless, flightless, and beatless phenotypes.)
In both humans and rodents, impaired signaling via cardiac G protein-coupled receptors is a characteristic feature of cardiac aging that has been linked to impaired heart rate control. 3 Specifically, a reduction in spontaneous heart rate variability and in the maximum heart rate achieved during stress in older mammals has been linked to impaired autonomic modulation of the heart rate; a reduced ␤-adrenergic component is particularly remarkable in this regard. 1, 3 Hence, infusions of catecholamines at rest increase heart rate to a lesser extent in older versus younger mammals. 3 Although a primitive autonomic nervous system in insects has been reported, 30 specific details are lacking. A link between ␤-adrenergic stimulation of heart rate and Ca 2ϩ release via ryanodine receptor in mammalian cells has been recently uncovered. 31, 32 More specifically, ␤-adrenergic receptor stimulation exerts its action via recruitment of ryanodine receptors to participate in the preaction potential Ca 2ϩ release, and this amplifies the resultant involvement and slope of the pacemaker potential via the Na ϩ -Ca 2ϩ exchange mechanism noted above. 33 Thus, initial genome screens for common genetic bases for the prominent age-associated decline in heart rate control in Drosophila (Figure) will surely focus on genes that code for proteins for specific ion channels and Ca 2ϩ regulation and for G protein-signaling components. Still other mechanisms involved in altered heart rate control with aging need to be addressed. The number of sinoatrial nodal cells has been reported to decrease dramatically with age. 3 Factors that govern impulse generation and conduction among cells, which are required for an impulse to exit the sinus node, also need to be addressed. Heart rate control is like a symphony in that many mechanisms act together to determine heart rate. It is likely that changes in the expression of multiple genes could be involved.
In addition to the similarities between the age-associated changes in heart rate control in Drosophila versus human and rodents, 4 there are also apparent notable differences. In mammals, the basal or resting heart rate is unchanged or changes minimally with adult age. 1, 3 In Drosophila, an age-associated decline in the prestress heart rate with aging, which was marked as the age-associated maximum heart rate decline during stress in some experiments, was observed. 4 It might be argued that the prestress heart rate in flies studied by Paternostro et al 4 is not basal or that, in fact, the decline in the maximum stressed heart rate in flies may be linked to the same mechanism that underlies the prominent decline observed in prestress heart rate. If this were the case, it might complicate the extrapolation of insights from the fly genome to humans. Additionally, the maximum heart rate achievable by external pacing does not decline with age in mammals 34 as it does in flies. 4 Another apparent difference between humans and flies is that heart rate variability invariably has been found to decline with advancing age in humans 3 whereas in flies, Paternostro et al 4 have observed an increase in its variability with age. 4 Heart rate measured in Drosophila before and during the stress of increased temperature. 4 Heart rate at exhaustion during upright, seated cycle ergometry of varying age. Data from Fleg JL, O'Connor F, Gerstenblith G, Becker LC, Clulow J, Schulman SP, Lakatta EG. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol. 1995;78:890 -900.
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Paternostro et al 4 propose a temperature increase or external pacing to increase heart rate as stressors that could be used in conjunction with genetic screening. However, are these stressors appropriate? Might temperature or external pacing act to change heart rate via some other mechanism than those that underlie the loss of heart rate control with aging in mammals, eg, adrenergic receptor stimulation, stretch, or a change in the number of pacemaker cells and the communication among or between these cells and surrounding, nonspecialized cells with respect to pacemaker function? Aerobic stress, such as exercise, is a common stress used in studies of heart rate reserve in humans and rodents and would be of interest to use in flies. Previous studies, in fact, have observed an age-associated reduction in work capacity in Drosophila as a function of age. 35 In this study, the ability of flies kept in a vial to climb up the side of the vial after mechanical stimulation reduced with age over the same age range as the heart rate declined in the Figure. As noted, the heart rate deficit with aging in humans and rodents or Drosophila is a prominent component of diminished cardiac reserve and is thus a major factor underlying the ageassociated reduction in aerobic work capacity.
In summary, the fly seems not an unwelcome addition to the proverbial ointment of cardiac aging but rather may prove to be a valuable new model in the study of cardiac aging, particularly with respect to interactions between age, lifestyle, disease, and genetics involved in the determination of cardiovascular structure and function during the later part of a human's existence. The extent of the relevance of this type of information gleaned from studies in flies to mice and humans remains to be demonstrated. Although the study by Paternostro et al 4 has taken the first big step, it is clear that progress in the genetics of cardiac aging in flies requires additional discoveries to be made in defining the Drosophila cardiac phenotype that evolves during aging. Fly physiologists, take heed!
